Drug Trial Radar · NCT05330325
A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow
Last checked: Nov 20, 2026Latest source record: Jun 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
412
Actual
Start
Aug 10, 2022
Primary completion
Aug 5, 2024
Study completion Oct 29, 2027
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Apr 15, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 10 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study compares two medicines for treatment of children born small and who stay small, or with Turner Syndrome, Noonan Syndrome, or idiopathic short stature. The purpose of the study is to see how well treatment with somapacitan works compared to treatment with Norditropin®. Somapacitan is a new medicine, and Norditropin® is a medicine doctors can already prescribe in some countries. The study will last for upto 5.5 years. The participants will either get somapacitan once a week up to 5.5 years or Norditropin® once a day for 1 year followed by somapacitan once a week for up to 4.5 years. Which treatment the participants get is decided by chance.
Conditions
- SGA, Turner Syndrome, Noonan Syndrome, ISS
Interventions
SomapacitanDrug
Somapacitan will be administered subcutaneously (s.c.) once weekly using PDS290 pen-injector.
Norditropin®Drug
Norditropin® will be administered s.c. once daily using FlexPro® pen-injector.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Height velocity reported separately for small for gestational age (SGA), Turner syndrome (TS), Noonan syndrome (NS) and idiopathic short stature (ISS)Time frame: From baseline (week 0) to visit 7 (week 52)
Locations
199 sites in 33 countries. Site status is shown where the registry gives one.
Univ of AL at Birmingham_BRM
Birmingham, Alabama
Children's Hospital Los Angeles - Endocrinology
Los Angeles, California
Sutter Valley Med Fdt Ped Endo
Sacramento, California
Rady Childrens Hosp San Diego
San Diego, California
Children's Hospital Colorado
Aurora, Colorado
Rocky Mt Ped and Endo
Centennial, Colorado
Ped Endo Assoc PC-G.V
Greenwood Village, Colorado
Nemours/AI duPont Hosp-Chld
Wilmington, Delaware
Childrens National Medical Ctr
Washington D.C., District of Columbia
Nemours Chld Clnc Jacksonville
Jacksonville, Florida
Atlanta Diabetes Associates
Atlanta, Georgia
St. Luke's Children's Endo
Boise, Idaho
Rocky Mt Clin Res, LLC
Idaho Falls, Idaho
Riley Hosp for Child-Indiana U
Indianapolis, Indiana
University OF Iowa
Iowa City, Iowa
UMass Medical School
Worcester, Massachusetts
Univ of Minnesota M.C.H.
Minneapolis, Minnesota
Children's Minnesota
Saint Paul, Minnesota
Univ of Mississippi Med Ctr
Jackson, Mississippi
The Children's Mercy Hospital
Kansas City, Missouri
Goryeb Children's Hospital
Morristown, New Jersey
UBMD Peds-Div of Endo/Diabetes
Buffalo, New York
NYU Langone Hospital-LI
Garden City, New York
NYU Langone Hospital-LI
Mineola, New York
WakeMed Childn Endo-Dbt_Raleig
Raleigh, North Carolina
Akron Children's Hospital
Akron, Ohio
CCHMC_Cinc
Cincinnati, Ohio
Univ Oklahoma Sci Ctr OK City
Oklahoma City, Oklahoma
UPMC Child Hosp-Pittsburgh
Pittsburgh, Pennsylvania
UT Southwestern Med Cntr
Dallas, Texas
Cook Children's Medical Center
Fort Worth, Texas
Consano Clinical Research, LLC
Shavano Park, Texas
University Of Virginia Hospital
Charlottesville, Virginia
MultiCare Inst for Res & Innov
Tacoma, Washington
Marshfield Clinic
Marshfield, Wisconsin
Krankenhaus der Stadt Dornbirn
Dornbirn, Austria
LKH St. Poelten, Kinder-und Jugendheilkunde
Sankt Pölten, Austria
Salzkammergut-Klinikum Vöcklabruck
Vöcklabruck, Austria
Kepler Universitätsklinikum GmbH - Med Campus IV (vorm.LFKK)
Linz, Upper Austria, Austria
UZ Brussel
Brussels, Belgium
Showing 40 of 199 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.